Showing 921 - 940 results of 56,277 for search '(( 5 ((step decrease) OR (we decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924
  5. 925

    Statistically significant correspondence between human psoriasis and mouse psoriasiform phenotypes: Proportion of psoriasiform-increased to psoriasiform-decreased transcripts. by William R. Swindell (175427)

    Published 2011
    “…<p>Genes significantly increased or decreased in human psoriasis were identified and the expression of orthologous genes was studied in the K5-Tie2 phenotype (A and B), the IMQ phenotype (C and D), the K14-AREG phenotype on ear skin (E and F), the K14-AREG phenotype on tail skin (G and H), the K5-Stat3C phenotype (I and J), and the K5-TGFβ1 phenotype (K and L). …”
  6. 926
  7. 927
  8. 928
  9. 929

    Phospho-ERK level is decreased in 3D spheroids. by Keven Huang (675616)

    Published 2014
    “…(<b>C</b>) At 100,000 cells per spheroid, HeyA8 cells treated with SDF-1α and PMA showed activation of phospho-ERK levels. (**, P <0.005 vs Adh, 1-way ANOVA). …”
  10. 930
  11. 931

    IgG binds to GluN2B and decreases CaMKII binding to GluN2B. by Dayton J. Goodell (559732)

    Published 2014
    “…Bar graphs indicate mean ± s.e.m, and GST-GluN2B detection is shown as a loading control. …”
  12. 932
  13. 933
  14. 934
  15. 935
  16. 936

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
  17. 937
  18. 938
  19. 939
  20. 940

    Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges. by Jaclyn M. Kline (9565161)

    Published 2020
    “…(B) Tactile sensitivity in sensitized mice preventatively treated with imatinib or NT and then 10 daily MI challenges. Results reported as mean ± SEM of the percent decrease from baseline in the withdrawal threshold for each treatment group, n = 18/treatment group. …”